ES8702370A1 - Un procedimiento para la preparacion de sales de imidazolio. - Google Patents

Un procedimiento para la preparacion de sales de imidazolio.

Info

Publication number
ES8702370A1
ES8702370A1 ES548797A ES548797A ES8702370A1 ES 8702370 A1 ES8702370 A1 ES 8702370A1 ES 548797 A ES548797 A ES 548797A ES 548797 A ES548797 A ES 548797A ES 8702370 A1 ES8702370 A1 ES 8702370A1
Authority
ES
Spain
Prior art keywords
alkyl
hydrogen
imidazolium salts
oxoethyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES548797A
Other languages
English (en)
Spanish (es)
Other versions
ES548797A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES8702370A1 publication Critical patent/ES8702370A1/es
Publication of ES548797A0 publication Critical patent/ES548797A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES548797A 1984-11-13 1985-11-12 Un procedimiento para la preparacion de sales de imidazolio. Expired ES8702370A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/670,776 US4609670A (en) 1984-11-13 1984-11-13 Imidazolium hypoglycemic agents

Publications (2)

Publication Number Publication Date
ES8702370A1 true ES8702370A1 (es) 1987-01-01
ES548797A0 ES548797A0 (es) 1987-01-01

Family

ID=24691822

Family Applications (1)

Application Number Title Priority Date Filing Date
ES548797A Expired ES8702370A1 (es) 1984-11-13 1985-11-12 Un procedimiento para la preparacion de sales de imidazolio.

Country Status (21)

Country Link
US (1) US4609670A (enExample)
EP (1) EP0182533B1 (enExample)
JP (1) JPH0647576B2 (enExample)
KR (1) KR880001231B1 (enExample)
CN (1) CN1013444B (enExample)
AR (1) AR244671A1 (enExample)
AT (1) ATE46505T1 (enExample)
AU (1) AU574532B2 (enExample)
CA (1) CA1266673A (enExample)
DE (1) DE3573114D1 (enExample)
DK (1) DK164547C (enExample)
EG (1) EG17707A (enExample)
ES (1) ES8702370A1 (enExample)
GR (1) GR852707B (enExample)
HU (1) HU195490B (enExample)
IE (1) IE59093B1 (enExample)
NZ (1) NZ214088A (enExample)
PH (1) PH21656A (enExample)
PT (1) PT81439B (enExample)
SU (1) SU1424733A3 (enExample)
ZA (1) ZA858499B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656261A (en) * 1995-01-18 1997-08-12 The Picower Institute For Medical Research Preventing and reversing advanced glycosylation endproducts
EP0808163B1 (en) * 1995-01-18 2003-07-23 Alteon, Inc. Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts
NO315930B1 (no) * 1995-01-18 2003-11-17 Picower Inst For Medical Res T Anvendelse av tiazoliumforbindelser ved fremstilling av farmasöytiske preparater, preparater som inneholder forbindelsene, samt nyetiazoliumforbindelser
US20040198795A1 (en) * 1996-05-08 2004-10-07 Wagle Dilip R Substituted imidazoliums and methods of use therefor
US6121300A (en) * 1998-11-10 2000-09-19 Wagle; Dilip R. Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
US6781039B2 (en) * 2002-05-07 2004-08-24 Stine Seed Farm, Inc. Soybean cultivar S010360
DE102006028264B4 (de) * 2006-01-10 2008-12-11 Uwe Pisching Sägebock
CN100460395C (zh) * 2006-07-06 2009-02-11 云南大学 芳环和杂环酰甲基咪唑盐类化合物及其制备方法
CA2791738C (en) * 2010-03-01 2020-06-09 Gtx, Inc. Aryl imidazolyl compounds for the treatment of cancer
CN113811305A (zh) * 2019-03-11 2021-12-17 诺西恩医疗公司 带电的离子通道阻滞剂及其使用方法
US11377422B2 (en) 2019-03-11 2022-07-05 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CA3155568A1 (en) 2019-11-06 2021-05-14 Bridget Mccarthy Cole Charged ion channel blockers and methods for use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852301A (en) * 1973-06-21 1974-12-03 Squibb & Sons Inc Enol betaines of imidazoles
US4017631A (en) * 1974-11-19 1977-04-12 Janssen Pharmaceutica N.V. Imidazolium salts
GB1533706A (en) * 1976-03-01 1978-11-29 Ici Ltd Fungicidal imidazoles and 1,2,4-triazoles
DE2643563A1 (de) * 1976-09-28 1978-03-30 Bayer Ag Alpha-(4-biphenylyl)-benzyl-azolium- salze, verfahren zu ihrer herstellung sowie ihre verwendung zur bekaempfung von mikroorganismen
DE2714290A1 (de) * 1977-03-31 1978-10-05 Bayer Ag Fungizide mittel
JPS5479278A (en) * 1977-12-05 1979-06-25 Nippon Soda Co Ltd Imidazolium halide
JPS58150567A (ja) * 1982-03-03 1983-09-07 Kissei Pharmaceut Co Ltd 新規な1,3−二置換イミダゾ−ル誘導体およびその製造方法
US4581370A (en) * 1983-07-12 1986-04-08 Schering A.G. Antiarrhythmic imidazoliums

Also Published As

Publication number Publication date
NZ214088A (en) 1988-09-29
PT81439B (pt) 1988-03-03
EP0182533A2 (en) 1986-05-28
DK164547C (da) 1992-11-30
IE59093B1 (en) 1994-01-12
CN1013444B (zh) 1991-08-07
DK515285D0 (da) 1985-11-08
HU195490B (en) 1988-05-30
HUT39164A (en) 1986-08-28
CN85108115A (zh) 1986-07-30
PT81439A (en) 1985-12-01
KR880001231B1 (ko) 1988-07-12
GR852707B (enExample) 1986-03-10
PH21656A (en) 1988-01-13
CA1266673A (en) 1990-03-13
DE3573114D1 (en) 1989-10-26
AR244671A1 (es) 1993-11-30
KR860004029A (ko) 1986-06-16
IE852822L (en) 1986-05-13
SU1424733A3 (ru) 1988-09-15
ZA858499B (en) 1987-06-24
JPS61122212A (ja) 1986-06-10
ATE46505T1 (de) 1989-10-15
EP0182533A3 (en) 1987-06-03
AU574532B2 (en) 1988-07-07
AU4973785A (en) 1986-05-22
ES548797A0 (es) 1987-01-01
EP0182533B1 (en) 1989-09-20
JPH0647576B2 (ja) 1994-06-22
US4609670A (en) 1986-09-02
DK164547B (da) 1992-07-13
DK515285A (da) 1986-05-14
EG17707A (en) 1990-08-30

Similar Documents

Publication Publication Date Title
EP1035123A4 (en) NEW HETEROCYCLIC CONNECTIONS
DK0567982T3 (da) Azolforbindelser, deres fremstilling og anvendelse
AU1433588A (en) 1-phenyl-3-naphthalenyloxypropanamines
GEP19970806B (en) Herbicidal imidazolinone composition
NO975664L (no) Imidazolderivater som er nyttige som syntesemellomprodukter
IL77717A (en) Pharmaceutical compositions containing derivatives of imidazole,their preparation and some novel compounds of this type
ES8609272A1 (es) Un procedimiento para preparar derivados de hidantoina
AU554476B2 (en) Triazole derivatives
NZ332012A (en) 4-[(thien-3-yl)methyl] imidazole derivatives having alpha-2-adrenoceptor agonistic activity
AU546388B2 (en) ;het;-substituted-3-triazolylpropanes
ATE36316T1 (de) Gegen psoriasis wirkende naphthalin-verbindungen.
GR3001671T3 (en) Isoxazolylethanol derivatives
AU1586588A (en) Fungicidal derivatives of propenoic acid and processes for their preparation
ES8601990A1 (es) Un procedimiento para preparar 2-arilimidazo (4,5-c) piridi-nas.
DE3369512D1 (en) Triazole antifungal agents
ZA906446B (en) Therapeutic agents for the treatment of peptic ulcer disease